Chaperone proteins as single component reagents to assess antibody nonspecificity

References

• Frese K, Eisenmann M, Ostendorp R. An automated immunoassay for early specificity profiling of antibodies. MAbs. 2013;5(2):279–87. doi:10.4161/mabs.23539. PMID:23412646
   PubMed Web of Science ®Google Scholar
• Birtalan S, Zhang Y, Fellouse FA, Shao L, Schaefer G, Sidhu SS. The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J Mol Biol. 2008;377(5):1518–28. doi:10.1016/j.jmb.2008.01.093. PMID:18336836
   PubMed Web of Science ®Google Scholar
• Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science. 2003;301(5638):1374–7. doi:10.1126/science.1086907. PMID:12920303
   PubMed Web of Science ®Google Scholar
• Hotzel I, Theil F–P, Bernstein LJ, Prabhu S, Deng R, Quintana L, Lutman J, Sibia R, Chan P, Bumbaca D, et al. A strategy for risk mitigation of antibodies with fast clearance. MAbs. 2012;4(6):753–60. doi:10.4161/mabs.22189. PMID:23778268
   PubMed Web of Science ®Google Scholar
• Xu Y, Roach W, Sun T, Jain T, Prinz B, Yu T–Y, Torrey J, Thomas J, Bobrowicz P, Vásquez M, et al. Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS–based, high–throughput selection and analytical tool. Protein Eng Des Sel. 2013;26(10):663–70. doi:10.1093/protein/gzt047. PMID:24046438
   PubMed Web of Science ®Google Scholar
• Kelly RL, Sun T, Jain T, Caffry I, Yu Y, Cao Y, Lynaugh H, Brown M, Vásquez M, Wittrup KD, et al. High throughput cross–interaction measures for human IgG1 antibodies correlate with clearance rates in mice. MAbs. 2015;7(4):770–7. doi:10.1080/19420862.2015.1043503. PMID:26047159
   PubMed Web of Science ®Google Scholar
• Lindquist S, Craig EA. The heat–shock proteins. Annu Rev Genet. 1988;22:631–77. doi:10.1146/annurev.ge.22.120188.003215. PMID:2853609
   PubMed Web of Science ®Google Scholar
• Lindquist S. The heat–shock response. Annu Rev Biochem. 1986;55:1151–91. doi:10.1146/annurev.bi.55.070186.005443. PMID:2427013
   PubMed Web of Science ®Google Scholar
• Mashaghi A, Bezrukavnikov S, Minde DP, Wentink AS, Kityk R, Zachmann–Brand B, Mayer MP, Kramer G, Bukau B, Tans SJ. Alternative modes of client binding enable functional plasticity of Hsp70. Nature. 2016;539(7629):448–451. doi:10.1038/nature20137. PMID:27783598
   PubMed Web of Science ®Google Scholar
• Feder ME, Hofmann GE. Heat–shock proteins, molecular chaperones, and the stress response: Evolutionary and ecological physiology. Annu Rev Physiol. 1999;61:243–82. doi:10.1146/annurev.physiol.61.1.243. PMID:10099689
   PubMed Web of Science ®Google Scholar
• Kim YE, Hipp MS, Bracher A, Hayer–Hartl M, Hartl FU. Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem. 2013;82:323–55. doi:10.1146/annurev-biochem-060208-092442. PMID:23746257
   PubMed Web of Science ®Google Scholar
• Jain T, Sun T, Durand S, Hall A, Houston NR, Nett JH, Sharkey B, Bobrowicz B, Caffry I, Yu Y, et al. Biophysical properties of the clinical–stage antibody landscape. Proc Natl Acad Sci. 2017;114(5):944–949. doi:10.1073/pnas.1616408114. PMID:28096333
   PubMed Web of Science ®Google Scholar
• Shimizu T, Yonesaka K, Hayashi H, Iwasa T, Haratani K, Yamada H, Ohwada S, Kamiyama E, Nakagawa K. Phase 1 study of new formulation of patritumab (U3–1287) Process 2, a fully human anti–HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non–small cell lung cancer. Cancer Chemother Pharmacol. 2017;79(3):489–495. doi:10.1007/s00280-016-3231-3. PMID:28144730
   PubMed Web of Science ®Google Scholar
• Wakui H, Yamamoto N, Nakamichi S, Tamura Y, Nokihara H, Yamada Y, Tamura T. Phase 1 and dose–finding study of patritumab (U3–1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol. 2014;73:511–6. doi:10.1007/s00280-014-2375-2. PMID:24442032
   PubMed Web of Science ®Google Scholar
• Fracasso PM, Burris H, Arquette MA, Govindan R, Gao F, Wright LP, Goodner SA, Greco FA, Jones SF, Willcut N, et al. A phase 1 escalating single–dose and weekly fixed–dose study of cetuximab: Pharmacokinetic and pharmacodynamic rationale for dosing. Clin Cancer Res. 2007;13:986–93. doi:10.1158/1078-0432.CCR-06-1542. PMID:17289894
   PubMed Web of Science ®Google Scholar
• Krens LL, Baas JM, De Jong FA, Guchelaar HJ, Gelderblom H. Pharmacokinetics of panitumumab in a patient with liver dysfunction: A case report. Cancer Chemother Pharmacol. 2014;73:429–33. doi:10.1007/s00280-013-2353-0. PMID:24258455
   PubMed Web of Science ®Google Scholar
• Bruno R, Washington CB, Lu JF, Lieberman G, Banken L, Klein P. Population pharmacokinetics of trastuzumab in patients with HER2+ metastatic breast cancer. Cancer Chemother Pharmacol. 2005;56:361–9. doi:10.1007/s00280-005-1026-z. PMID:15868146
   PubMed Web of Science ®Google Scholar
• Vermeire S, O'Byrne S, Keir M, Williams M, Lu TT, Mansfield JC, Lamb CA, Feagan BG, Panes J, Salas A, et al. Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial. Lancet. 2014;384:309–18. PMID:24814090
   PubMed Web of Science ®Google Scholar
• Lartruvo® [package insert]. Eli Lilly and Company, Indianapolis, IN; 2016. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761038lbl.pdf
   Google Scholar
• Wang XX, Cho YK, Shusta E V. Mining a yeast library for brain endothelial cell–binding antibodies. Nat Methods. 2007;4:143–5. doi:10.1038/nmeth993. PMID:17206151
   PubMed Web of Science ®Google Scholar
• Cho Y, Chen I, Wei X, Li L, Shusta E. A yeast display immunoprecipitation method for efficient isolation and characterization of antigens. J Immunol Methods. 2009;341(1–2):117–26. doi:10.1016/j.jim.2008.11.005. doi:10.1016/j.jim.2008.11.005. PMID:19041873
   PubMed Web of Science ®Google Scholar
• Chao G, Lau WL, Hackel BJ, Sazinsky SL, Lippow SM, Wittrup KD. Isolating and engineering human antibodies using yeast surface display. Nat Protoc. 2006 1(2):755–68. doi:10.1038/nprot.2006.94. PMID:17406305
   PubMed Web of Science ®Google Scholar
• VanDeventer JA, Wittrup KD. Yeast surface display for antibody isolation: Library construction, library screening, and affinity maturation. Methods Mol Biol. 2014;1131:151–81. doi:10.1007/978-1-62703-992-5_10. PMID:24515465
   PubMedGoogle Scholar
• Traxlmayr MW, Kiefer JD, Srinivas RR, Lobner E, Tisdale AW, Mehta NK, Yang NJ, Tidor B, Wittrup KD. Strong enrichment of aromatic residues in binding sites from a charge–neutralized hyperthermostable Sso7D scaffold library. J Biol Chem. 2016;291:22496–508. doi:10.1074/jbc.M116.741314. PMID:27582495
   PubMed Web of Science ®Google Scholar
• García–Cardeña G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 1998;392(6678):821–4. doi:10.1038/33934. PMID:9580552
   PubMed Web of Science ®Google Scholar
• Hageman J, Kampinga HH. Computational analysis of the human HSPH/HSPA/DNAJ family and cloning of a human HSPH/HSPA/DNAJ expression library. Cell Stress Chaperones. 2009;14:1–21. doi:10.1007/s12192-008-0060-2. PMID:18686016
   PubMed Web of Science ®Google Scholar